| ASSET | YEAR | % RETURN |
|---|---|---|
Cidara Therapeutics (CDTX) | 2015 | 2,045% |
Galapagos NV ADR (GLPG) | 2015 | 231.72% |
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Caesars Entertainment (CZR) | 2015 | 159.43% |
Ultragenyx (RARE) | 2015 | 152.54% |
Globant (GLOB) | 2015 | 142.78% |
Pampa Energia SA ADR (PAM) | 2015 | 104.07% |
Ligand Pharmaceuticals (LGND) | 2015 | 102.01% |
National Beverage (FIZZ) | 2015 | 100.89% |
Dycom Industries (DY) | 2015 | 98.07% |
Universal Display (OLED) | 2015 | 94.64% |
Penumbra (PEN) | 2015 | 79.37% |
Halozyme Therapeutics (HALO) | 2015 | 77.38% |
Applied Digital (APLD) | 2015 | 75.26% |
Transportadora de Gas del Sur SA ADR (TGS) | 2015 | 74.5% |
Grupo Financiero Galicia SA ADR (GGAL) | 2015 | 71.55% |
FirstService (FSV) | 2015 | 66.89% |
Corcept Therapeutics (CORT) | 2015 | 65.45% |
TAL Education (TAL) | 2015 | 65.26% |
EPAM Systems (EPAM) | 2015 | 64.58% |
Walker & Dunlop (WD) | 2015 | 63.23% |
Primo Brands (PRMB) | 2015 | 62.69% |
Stonex (SNEX) | 2015 | 62.11% |
Supernus Pharmaceuticals (SUPN) | 2015 | 60.57% |
NexGen Energy (NXE) | 2015 | 59.75% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
